“…The complex structure of solid tumors together with the interactions of cancer cells with the surrounding stroma and matrix components stimulate the initiation of a premetastatic niche that promotes metastasis to distant sites (8,(43)(44)(45) (Figure 7A). Alterations in the expression profiles of ECM structural components, including among others, PGs, hyaluronan, growth factor receptors, MMPs, and signaling stimulators, foresee the variations in cancer cell behavior, and construct the homes for metastasis (7,(46)(47)(48). Even though the significance of ERb is less clarified in breast cancer progression than its isoform, ERa, probably due to the existence of several alternatively spliced ERb variants; however, the potential of ERb targeting in aggressive breast cancer subtypes, as TNBC, has gained attention over the years (49).…”